Worldwide Healthcare Trust (WWH), formerly known as Finsbury Worldwide Pharmaceutical, is a large British closed-ended investment fund, dedicated to investments in healthcare and biotechnology companies worldwide with the objective of achieving a high level of capital growth. Launched by Frostrow Capital LLP and managed by OrbiMed Capital LLC, it seeks to invest in growth stocks of large-cap companies with a market capitalisation of at least $5 billion. The Trust uses derivative and gearing transactions. It invests about 60% of the portfolio in larger companies, and at around 20% in smaller companies. When creating its portfolio, the fund utilises fundamental analysis with a bottom-up stock picking approach. Worldwide Healthcare Trust is known to benchmark its portfolio performance against the MSCI World Healthcare Index. The Worldwide Healthcare share price is listed on the London Stock Exchange and included in the FTSE 250 Index.
Check out Capital.com for the latest WWH share price.
最新股票文章

平頭哥分拆上市分析:阿里巴巴AI芯片業務的結構性風險與估值框架
阿里巴巴旗下平頭哥半導體擬分拆獨立上市,摩根大通估值介於250億至620億美元。本文從業務依賴度、估值方法論、地緣政策風險及港股科技板塊估值溢價等維度,解構該交易的結構性風險與分析框架。
14:16, 11 3月 2026


